Trotabresib (CC-90010) in combination with adjuvant temozolomide or concomitant temozolomide plus radiotherapy in patients with newly diagnosed glioblastoma.

Autor: Vieito M; Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Universidad Autonoma de Barcelona, Barcelona, Spain., Simonelli M; Department of Biomedical Sciences, Humanitas University, Milan, Italy.; IRCCS Humanitas Research Hospital, Milan, Italy., de Vos F; Department of Medical Oncology, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands., Moreno V; START Madrid-FJD, Hospital Universitario Fundación Jiménez Díaz, Madrid, Spain., Geurts M; Erasmus MC Cancer Institute, Rotterdam, the Netherlands., Lorenzi E; IRCCS Humanitas Research Hospital, Milan, Italy., Macchini M; Department of Oncology, IRCCS San Raffaele Scientific Institute, Milan, Italy., van den Bent MJ; Erasmus MC Cancer Institute, Rotterdam, the Netherlands., Del Conte G; Department of Oncology, IRCCS San Raffaele Scientific Institute, Milan, Italy., de Jonge M; Erasmus MC Cancer Institute, Rotterdam, the Netherlands., Martín-Soberón MC; Neuro-Oncology Unit, Department of Medical Oncology, Hospital Universitario 12 de Octubre, Madrid, Spain., Amoroso B; Centre for Innovation and Translational Research Europe, A Bristol Myers Squibb Company, Seville, Spain., Sanchez-Perez T; Centre for Innovation and Translational Research Europe, A Bristol Myers Squibb Company, Seville, Spain., Zuraek M; Bristol Myers Squibb, San Francisco, CA, USA., Hanna B; Bristol Myers Squibb, Princeton, NJ, USA., Aronchik I; Bristol Myers Squibb, San Francisco, CA, USA., Filvaroff E; Bristol Myers Squibb, San Francisco, CA, USA., Chang H; Bristol Myers Squibb, San Francisco, CA, USA., Mendez C; Centre for Innovation and Translational Research Europe, A Bristol Myers Squibb Company, Seville, Spain., Arias Parro M; Bristol Myers Squibb, Boudry, Switzerland., Wei X; Bristol Myers Squibb, Princeton, NJ, USA., Nikolova Z; Centre for Innovation and Translational Research Europe, A Bristol Myers Squibb Company, Seville, Spain., Sepulveda JM; Hospital Universitario 12 de Octubre, Madrid, Spain.

Publikováno v: Neuro-oncology advances [Neurooncol Adv] 2022 Oct 28; Vol. 4 (1), pp. vdac146. Date of Electronic Publication: 2022 Oct 28 (Print Publication: 2022).

Pneumatosis intestinalis in a radioactive iodine-refractory metastasic thyroid papillary carcinoma with BRAF ^V600E mutation treated with dabrafenib-trametinib: a case report.

Autor: Martín-Soberón MC; Medical Oncology Department, University Hospital 12 de Octubre, Madrid, Spain. mcms.207@gmail.com., Ruiz S; Nuclear Medicine Department, University Hospital 12 de Octubre, Madrid, Spain., De Velasco G; Medical Oncology Department, University Hospital 12 de Octubre, Madrid, Spain., Yarza R; Medical Oncology Department, University Hospital 12 de Octubre, Madrid, Spain., Carretero A; Medical Oncology Department, University Hospital 12 de Octubre, Madrid, Spain., Castellano D; Medical Oncology Department, University Hospital 12 de Octubre, Madrid, Spain., Sepúlveda-Sánchez JM; Medical Oncology Department, University Hospital 12 de Octubre, Madrid, Spain.

Publikováno v: Journal of medical case reports [J Med Case Rep] 2021 Mar 02; Vol. 15 (1), pp. 109. Date of Electronic Publication: 2021 Mar 02.

Phase II Trial of Palbociclib in Recurrent Retinoblastoma-Positive Anaplastic Oligodendroglioma: A Study from the Spanish Group for Research in Neuro-Oncology (GEINO).

Autor: Sepúlveda-Sánchez JM; Medical Oncology Department, Hospital Universitario, 12 de Octubre, Avda. Andalucía s/n, 28041, Madrid, Spain. sepulvedasanchez@seom.org., Gil-Gil M; Medical Oncology Department, Institut Català d'Oncologia L'Hospitalet, L'Hospitalet de Llobregat, Barcelona, Spain., Alonso-García M; Medical Oncology Department, Hospital Universitario Virgen del Rocío, Seville, Spain., Vaz Salgado MÁ; Medical Oncology Department, Hospital Universitario Ramón y Cajal, Madrid, Spain., Vicente E; Medical Oncology Department, Hospital Universitario Insular de Gran Canaria, Las Palmas, Spain., Mesía Barroso C; Medical Oncology Department, Institut Català d'Oncologia L'Hospitalet, L'Hospitalet de Llobregat, Barcelona, Spain., Rodríguez Sánchez Á; Medical Oncology Department, Hospital Universitario de León, León, Spain., Durán G; Unidad de Gestión Clínica Intercentros de Oncología Médica, Hospitales Universitarios Regional y Virgen de la Victoria, IBIMA, Málaga, Spain., De Las Peñas R; Medical Oncology Department, Consorcio Hospitalario Provincial de Castellón, Castellón, Spain., Muñoz-Langa J; Medical Oncology Department, Hospital Universitario y Policlínico La Fe, Valencia, Spain., Velasco G; Chemical Sciences Faculty, Universidad Complutense de Madrid, Madrid, Spain., Hernández-Laín A; Department of Pathology (Neuropathology), Instituto de Investigaciones Biomédicas I+12, Hospital Universitario, 12 de Octubre, Madrid, Spain., Hilario A; Radiology Department, Universitary Hospital, 12 de Octubre, Madrid, Spain., Navarro Martín M; Medical Oncology Department, Hospital Universitario de Salamanca, Salamanca, Spain., Benavides M; Unidad de Gestión Clínica Intercentros de Oncología Médica, Hospitales Universitarios Regional y Virgen de la Victoria, IBIMA, Málaga, Spain., Oleaga L; Radiology Department, Hospital Clínic Barcelona, Barcelona, Spain., Cantero Montenegro D; Neurooncology (Molecular Biology) Department, Hospital Universitario, 12 de Octubre, Madrid, Spain., Ruano Y; Molecular Pathology Unit, Hospital Universitario 12 de Octubre Research Institute, Madrid, Spain., Sánchez-Gómez P; Neurooncology Unit, Instituto de Salud Carlos III-UFIEC, Madrid, Spain., Martín-Soberón MC; Medical Oncology Department, Hospital Universitario, 12 de Octubre, Avda. Andalucía s/n, 28041, Madrid, Spain., Morales-Llombart R; MFAR Clinical Research, Barcelona, Spain., Pachón V; Medical Oncology Department, Hospital Universitario Ramón y Cajal, Madrid, Spain., Pineda E; Translational Genomics and Targeted Therapeutics in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain.; Medical Oncology Department, Hospital Clínic, Barcelona, Spain.

Publikováno v: Targeted oncology [Target Oncol] 2020 Oct; Vol. 15 (5), pp. 613-622.

Basic Clinical Radiobiology

Autor: Michael C. Joiner, Albert van der KogeJ. l

The sixth edition of this internationally successful text includes the many positive advances in radiation oncology that have occurred over the past decade, and which continue to keep radiation at the cutting edge of cancer therapy. As previously, a